Iloprost: Advanced Pharmaceutical Chemical for Vasodilatory and Anti-platelet Applications
Discover the potent vasodilatory and anti-platelet properties of Iloprost, a key pharmaceutical raw material.
Get a Quote & SampleProduct Core Value

Iloprost
Iloprost is a high-purity synthetic prostacyclin analogue renowned for its significant vasodilatory and anti-platelet aggregation capabilities. It plays a crucial role in treating various vascular conditions, offering a vital solution for patients and researchers in the pharmaceutical sector.
- Benefit from its potent vasodilatory action, crucial for treating conditions like pulmonary arterial hypertension.
- Leverage its anti-platelet properties to manage conditions such as Raynaud's phenomenon and scleroderma.
- Utilize this pharmaceutical raw material, supplied with GMP and USP certifications, ensuring quality and reliability in your research and production.
- Explore its applications in peripheral vascular research and as a key component in developing advanced cardiovascular therapies.
Advantages Offered by Iloprost
Therapeutic Efficacy
Iloprost's demonstrated efficacy in treating pulmonary arterial hypertension and Raynaud's phenomenon makes it a vital tool in modern medicine.
Research & Development
As a high-purity pharmaceutical chemical, Iloprost is instrumental in ongoing R&D for new vascular and cardiovascular treatments, supporting groundbreaking medical discoveries.
Quality Assurance
Compliance with GMP and USP standards ensures the consistent quality and safety of Iloprost, meeting the rigorous demands of the pharmaceutical industry.
Key Applications
Pulmonary Arterial Hypertension (PAH) Treatment
Iloprost is critically used to manage pulmonary arterial hypertension, improving blood flow in the lungs and alleviating symptoms for affected patients.
Raynaud's Phenomenon Management
Its vasodilatory effects make Iloprost an effective treatment for Raynaud's phenomenon, reducing the severity of attacks caused by cold or stress.
Scleroderma Treatment
Iloprost helps to improve blood circulation in patients with scleroderma, mitigating associated complications and improving tissue health.
Peripheral Vascular Research
This compound serves as an important research chemical for studies investigating peripheral vascular diseases and developing novel therapeutic strategies.